Showing results (21-30 of 317) with videos related to
Sort By:
Pageof 32
The Australian and New Zealand Journal of Psychiatry|December 1, 1989
The validity of the assessment of psychopathology in the psychosesP D McGorry, D L Copolov, B S SinghSchizophrenia Bulletin|January 1, 1990
Royal Park Multidiagnostic Instrument for Psychosis: Part I. Rationale and reviewP D McGorry, D L Copolov, B S SinghSchizophrenia Research|July 1, 1990
Current concepts in functional psychosis. The case for a loosening of associationsP D McGorry, D L Copolov, B S SinghThe American Journal of Psychiatry|April 28, 2000
Central auditory processing in patients with auditory hallucinationsC M McKay, D M Headlam, D L CopolovProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1996
Platelet [3H]dopamine uptake is differentially affected by neuroleptic drug treatment in schizophrenia and schizophreniform disorderB Dean, S Sundram, C Hill, et al.Endocrinology|December 1, 1995
Glucocorticoids inhibit D1B, but not D2, receptor-mediated effects on hypothalamic atrial natriuretic factor neuronsD Lee, W Huang, D L Copolov, et al.Peptides|January 1, 1994
Colocalization of atrial natriuretic factor and beta-endorphin in rat thymic macrophagesM Throsby, Z Yang, D L Copolov, et al.Life Sciences|January 1, 1996
Treatment with haloperidol or clozapine causes changes in dopamine receptors but not adenylate cyclase or protein kinase C in the rat forebrainD C Wan, B Dean, G Pavey, et al.Molecular and Cellular Neurosciences|December 1, 1994
D2 receptors mediate dopamine suppression of irANF release and pro-ANF mRNA expression of rat hypothalamic neurons in cultureD Lee, W Huang, D L Copolov, et al.Life Sciences|August 28, 2001
Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatumB Dean, T Hussain, E Scarr, et al.Pageof 32